Day

October 7, 2024
View/download as PDF • Independent Data Monitoring Committee recommended trial stop early due to overwhelming efficacy at pre-planned analysis• Phase IIIb clinical development of Airsupra was conducted by Avillion under an exclusive clinical co-development agreement with AstraZeneca• Airsupra (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in risk of severe asthma exacerbations in patients with...
Read More
CONTACT
+44 (0)203 764 9530
contact@avillionls.com
footer logo
popup logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.